Publication | Closed Access
Bioequivalence study of a valsartan tablet and a capsule formulation after single dosing in healthy volunteers using a replicated crossover design
21
Citations
0
References
2002
Year
Bioequivalence of the new 320 mg tablet with 2 marketed 160 mg capsules was demonstrated.